XML 27 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Medical Expenses Payable
9 Months Ended
Sep. 30, 2022
Insurance [Abstract]  
Medical Expenses Payable

7. Medical Expenses Payable

The following table is a detail of medical expenses payable as of September 30, 2022 and December 31, 2021:

 

 

 

September 30,
2022

 

 

December 31,
2021

 

Claims incurred but not paid

 

$

85,635

 

 

$

77,073

 

Capitation payable, risk-sharing payable, and other

 

 

85,760

 

 

 

48,813

 

 

 

$

171,395

 

 

$

125,886

 

Each period, we re-examine previously established outstanding claims reserve estimates based on actual claims submissions and other changes in facts and circumstances. As more complete claim information becomes available, we adjust the amount of the estimates and include the changes in estimates in claim costs in the period in which the change is identified. Substantially, all of the total claims paid by us are known and settled within the first year from the date of service, and substantially, all remaining claim amounts are paid within a three-year period.

The following table presents components of the change in medical expenses payable as of September 30, 2022 and 2021:

 

 

 

September 30,
2022

 

 

September 30,
2021

 

Claims incurred but not paid - beginning balance

 

$

77,073

 

 

$

82,391

 

Incurred related to:

 

 

 

 

 

 

Current year

 

 

293,036

 

 

 

246,352

 

Prior years

 

 

(15,757

)

 

 

(4,034

)

Total incurred, net of reinsurance

 

 

277,279

 

 

 

242,318

 

Payments related to:

 

 

 

 

 

 

Current year

 

 

212,028

 

 

 

170,496

 

Prior years

 

 

56,689

 

 

 

68,457

 

Total payments, net of reinsurance

 

 

268,717

 

 

 

238,953

 

Claims incurred but not paid - ending balance

 

 

85,635

 

 

 

85,756

 

Capitation payable, risk-sharing payable, and other

 

 

85,760

 

 

 

43,019

 

Total medical expenses payable

 

$

171,395

 

 

$

128,775

 

In March 2020, the COVID-19 outbreak was declared a pandemic. The COVID-19 virus disproportionately impacts older adults, especially those with chronic illnesses, which describes many of the seniors we serve. For the three months ended March 31, 2021, we experienced higher claims costs due to COVID-19 related inpatient admissions. However, for the remainder of 2021 we saw a decline in COVID-related utilization (compared to the first quarter of 2021) as vaccination rates improved across our senior population. The Delta and Omicron variants caused a rebound in COVID-related inpatient utilization during the second half of 2021 and first quarter of 2022, however, the increase in utilization did not reach first quarter of 2021 levels. While COVID had a less significant impact on the third quarter of 2022, we remain cautious of the potential impact of the COVID-19 in the future. The ultimate impact of COVID-19 to us and our financial condition is presently unknown, and we continue to monitor the impact of COVID-19 on our claims reserve estimate.

We re-examine previously established outstanding claims reserve estimates based on actual claims submissions and other changes in facts and circumstances. We recognized a favorable prior year development, excluding provision for adverse deviation, of $263 and $11,043 for the three and nine months ended September 30, 2022, respectively. The favorable prior year development was primarily due to better than expected claims recoveries and actual claims expense being less than expected.